封面
市場調查報告書
商品編碼
1287627

不孕症藥物市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2022年,全球不孕症藥物市場規模達到38億美元。展望未來,IMARC集團預計,到2028年,市場規模將達到52億美元,在2023-2028年期間表現出5.24%的成長率(CAGR)。

不孕症藥物是指用於治療不孕症和提高個人生殖健康的各種藥物。包括注射或口服。一些常用的不孕症藥物包括促性腺激素、芳香酶抑製劑、選擇性雌激素受體調節劑(SERM)、雙胍類藥物、排卵刺激劑、多巴胺激動劑和三環類抗抑鬱藥。作用是刺激女性的排卵和卵巢的卵泡發育,有助於恢復男性的睾丸激素水準並提高精子的品質,而實現懷孕。近年來,不孕症藥物在無法受孕的夫婦中得到了重視。

不孕症藥物的市場趨勢:

不孕症藥物透過恢復個人促進受孕的能力,協助提高夫妻懷孕的機會。因此,不孕症和流產的發生率上升是推動市場成長的主要因素。除此之外,各國政府採取了一些有利的計劃,以傳播有關現有治療方案的意識,催化對不孕症藥物的需求。此外,由於繁忙的工作安排、伴隨的壓力和生活方式的改變,慢性疾病的發病率有了明顯的增加,如癌症、肥胖、糖尿病、甲狀腺、多囊卵巢綜合症(PCOS)和更年期障礙。與此同時,由於延遲懷孕、晚婚和不健康的生活習慣,如過度飲酒、吸毒和吸煙,促使生育率下降,加速產品的採用率。此外,一些主要參與者從事研究和開發(R&D)活動,以推出療效更好、劑量要求更低、副作用更少的創新型不孕症藥物。此外,用於開發這些藥物的公共資金不斷增加,各監管機構對藥物的審批速度加快,這些都推動了市場的成長。其他因素,包括對學名藥需求的升級、醫療基礎設施的改善、消費者支出能力的提高、快速城市化和技術進步,也為市場成長提供了積極的推動力。

本報告回答的關鍵問題:

  • 迄今為止,全球不孕症藥物市場的表現如何,在未來幾年將如何表現?
  • COVID-19對全球不孕症藥物市場的影響是什麼?
  • 主要的區域市場是什麼?
  • 基於藥物類別的市場細分是什麼?
  • 基於給藥途徑的市場細分是什麼?
  • 基於配銷通路的市場分佈情況如何?
  • 基於終端用戶的市場細分是什麼?
  • 該行業價值鏈的各個階段是什麼?
  • 該行業的關鍵驅動因素和挑戰是什麼?
  • 全球不孕症藥物市場的結構是什麼,誰是主要參與者?
  • 該行業的競爭程度如何?

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 資料來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球不孕症藥物市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按藥物類別分類的市場

  • 促性腺激素
    • 市場趨勢
    • 市場預測
  • 芳香化酶抑製劑
    • 市場趨勢
    • 市場預測
  • 選擇性雌激素受體調節劑(SERMs)
    • 市場趨勢
    • 市場預測
  • 雙胍類藥物
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章:按給藥途徑分類的市場

  • 口服
    • 市場趨勢
    • 市場預測
  • 靜脈注射
    • 市場趨勢
    • 市場預測
  • 皮下注射
    • 市場趨勢
    • 市場預測
  • 肌內註射
    • 市場趨勢
    • 市場預測

第8章:按配銷通路分類的市場

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥店
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章:按終端用戶分類的市場

  • 男性
    • 市場趨勢
    • 市場預測
  • 女性
    • 市場趨勢
    • 市場預測

第十章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳洲
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章:價值鏈分析

第十三章:波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章:價格分析

第十五章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Theramex
Product Code: SR1623A385_Report

The global infertility drugs market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.24% during 2023-2028.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

Gonadotropin

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Others

Breakup by Route of Administration:

Oral

Intravenous

Subcutaneous

Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by End User:

Male

Female

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report:

  • How has the global infertility drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global infertility drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global infertility drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Infertility Drugs Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7   Market Breakup by Route of Administration

  • 7.1  Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Distribution Channel

  • 8.1  Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Livzon Pharmaceutical Group Inc. 
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5  Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6  Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7  Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8  Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9  Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10  Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players